Novo Nordisk A/S

Common Name
Novo Nordisk
Country
Denmark
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
78,554
Ticker
NOVO B
Exchange
NASDAQ COPENHAGEN A/S
Description
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, ...

Novo Nordisk's GHG Emissions Data Preview

In 2024, Novo Nordisk completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Novo Nordisk has also provided a category-level breakdown for 9 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Novo Nordisk’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novo Nordisk’s data sources below and access millions more through our Disclosure Search.

a. Novo Nordisk's Annual Report 2024
a. Novo Nordisk's Annual Report 2024
b. Novo Nordisk's Annual Report 2023
b. Novo Nordisk's Annual Report 2023
c. Novo Nordisk's Integrated Report 2021
c. Novo Nordisk's Integrated Report 2021

Insights into Novo Nordisk's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Novo Nordisk amounted to 259,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Novo Nordisk increased by 178.49%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Novo Nordisk's Scope 1 Emissions Over Time

201920202021202220232024025 k50 k75 k100 ktCO2e-13%+3%-1%+3%+9%
  • Total Scope 1
  • Year-over-Year Change

What are Novo Nordisk's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Novo Nordisk were 85,000 metric tons of CO₂ equivalent (tCO₂e). a

Has Novo Nordisk reduced its Scope 1 emissions over time?

Since 2019, Novo Nordisk's Scope 1 emissions have decreased by 1.16%, reflecting a declining long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2023), Novo Nordisk's Scope 1 emissions increased by 8.97%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Novo Nordisk's Scope 2 emissions?

In 2024, Novo Nordisk reported Scope 2 greenhouse gas (GHG) emissions of 16,000 tCO₂e using the market-based method and 174,000 tCO₂e using the location-based method. a

What methodology does Novo Nordisk use for Scope 2 reporting?

In 2024, Novo Nordisk reported its Scope 2 emissions using the market-based method and using the location-based method. a

Novo Nordisk's Scope 2 Emissions Over Time

201920202021202220232024045 k90 k135 k180 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Novo Nordisk's Value Chain Emissions

In 2024, Novo Nordisk reported 2,160,000 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Novo Nordisk includes a breakdown across 9 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Novo Nordisk's Scope 3 Emissions Over Time

2019202020212022202320240650 k1.3 M1.95 M2.6 MtCO2e-45%+1%+2885%-28%+24%
  • Total Scope 3
  • Year-over-Year Change

What are Novo Nordisk's Scope 3 emissions?

In 2024, Novo Nordisk reported total Scope 3 emissions of 2,160,000 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 99.91% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.09% came from downstream activities like product use, distribution, and end-of-life treatment. a

Has Novo Nordisk reduced its Scope 3 emissions over time?

Since 2019, Novo Nordisk's Scope 3 emissions have increased by 1,389.66%, reflecting a rising long-term trend in Scope 3 emissions over time. a c

Compared to the previous year (2023), Novo Nordisk's Scope 3 emissions increased by 23.92%, suggesting that the company faced challenges in reducing emissions across its value chain. a

What categories of Scope 3 emissions does Novo Nordisk disclose?

In 2024, Novo Nordisk reported emissions for 9 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Novo Nordisk's Scope 3 emissions?

In 2024, the largest contributors to Novo Nordisk's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 1,215,000 tCO₂e (56.25%)
  • Capital Goods (Cat. 2): 465,000 tCO₂e (21.53%)
  • Business Travel (Cat. 6): 188,000 tCO₂e (8.7%)

Novo Nordisk's Scope 3 Emissions by Categories

Business Travel(Cat. 6)(8.7%)Capital Goods(Cat. 2)(21.5%)Purchased Goods andServices (Cat. 1)(56.3%)

Insights into Novo Nordisk’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Novo Nordisk reported Scope 1 greenhouse gas (GHG) emissions of 85,000 tCO₂e and total revenues of USD 40,472 millions. This translates into an emissions intensity of 2.1 tCO₂e per millions USD. a

Novo Nordisk's Scope 1 Emissions Intensity Compared to Peers

5005,00050,0001,000,00010,000,000Scope 1 Emissions (tCO2e)2001,00010,00050,000200,000Revenues (Millions of USD)ZCTOSanofiYear: 2024Scope 1: 298,485 tCO2eRevenue: $M 46,085Scope 1 Intensity: 6.48 tCO2e/$MBristol-Myers SquibbYear: 2024Scope 1: 206,726 tCO2eRevenue: $M 48,300Scope 1 Intensity: 4.28 tCO2e/$MSanten PharmaceuticalYear: 2024Scope 1: 17,372 tCO2eRevenue: $M 1,994Scope 1 Intensity: 8.71 tCO2e/$MBiogenYear: 2024Scope 1: 56,611 tCO2eRevenue: $M 9,676Scope 1 Intensity: 5.85 tCO2e/$MOno PharmaceuticalYear: 2024Scope 1: 8,100 tCO2eRevenue: $M 3,319Scope 1 Intensity: 2.44 tCO2e/$MKalbe FarmaYear: 2024Scope 1: 19,895 tCO2eRevenue: $M 2,028Scope 1 Intensity: 9.81 tCO2e/$MZZZhangzhou Pientzehuang PharmaceuticalYear: 2023Scope 1: 2,301 tCO2eRevenue: $M 1,415Scope 1 Intensity: 1.63 tCO2e/$MChugai PharmaceuticalYear: 2024Scope 1: 51,143 tCO2eRevenue: $M 7,456Scope 1 Intensity: 6.86 tCO2e/$MOtsuka HoldingsYear: 2021Scope 1: 1,030,000 tCO2eRevenue: $M 13,021Scope 1 Intensity: 79.10 tCO2e/$MAmgenYear: 2024Scope 1: 147,000 tCO2eRevenue: $M 33,424Scope 1 Intensity: 4.40 tCO2e/$MJiangsu Hengrui PharmaceuticalsYear: 2024Scope 1: 8,517 tCO2eRevenue: $M 3,835Scope 1 Intensity: 2.22 tCO2e/$MOrganon & CoYear: 2024Scope 1: 34,200 tCO2eRevenue: $M 6,403Scope 1 Intensity: 5.34 tCO2e/$MAbbVieYear: 2024Scope 1: 300,072 tCO2eRevenue: $M 56,334Scope 1 Intensity: 5.33 tCO2e/$MDaiichi SankyoYear: 2024Scope 1: 91,836 tCO2eRevenue: $M 10,576Scope 1 Intensity: 8.68 tCO2e/$MGSKYear: 2024Scope 1: 521,000 tCO2eRevenue: $M 39,374Scope 1 Intensity: 13.23 tCO2e/$MAstraZenecaYear: 2024Scope 1: 125,386 tCO2eRevenue: $M 39,894Scope 1 Intensity: 3.14 tCO2e/$MBayerYear: 2024Scope 1: 1,880,000 tCO2eRevenue: $M 48,499Scope 1 Intensity: 38.76 tCO2e/$MCCCSPC Pharmaceutical GroupYear: 2024Scope 1: 474,567 tCO2eRevenue: $M 4,327Scope 1 Intensity: 109.67 tCO2e/$MRoche HoldingYear: 2024Scope 1: 245,832 tCO2eRevenue: $M 68,903Scope 1 Intensity: 3.57 tCO2e/$MMerck & Co IncYear: 2024Scope 1: 721,200 tCO2eRevenue: $M 64,168Scope 1 Intensity: 11.24 tCO2e/$MRecordatiYear: 2024Scope 1: 37,280 tCO2eRevenue: $M 2,437Scope 1 Intensity: 15.30 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MTTTong Ren Tang TechnologiesYear: 2024Scope 1: 30,000 tCO2eRevenue: $M 1,086Scope 1 Intensity: 27.62 tCO2e/$MKyowa KirinYear: 2024Scope 1: 16,133 tCO2eRevenue: $M 3,157Scope 1 Intensity: 5.11 tCO2e/$MOOOrion OyjYear: 2024Scope 1: 5,625 tCO2eRevenue: $M 1,605Scope 1 Intensity: 3.50 tCO2e/$MNovo NordiskYear: 2024Scope 1: 85,000 tCO2eRevenue: $M 40,472Scope 1 Intensity: 2.10 tCO2e/$M

How does Novo Nordisk's GHG emissions intensity compare to its peers?

In 2024, Novo Nordisk reported a Scope 1 emissions intensity of 2.1 tCO₂e per millions USD. Compared to the peer group median of 6.48 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Novo Nordisk rank on GHG emissions intensity within its industry?

In 2024, Novo Nordisk ranked 2 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Novo Nordisk among the top performers, with one of the lowest emissions intensities relative to peers. a

Insights into Novo Nordisk's Total Carbon Footprint

In 2024, Novo Nordisk reported a total carbon footprint of 2,419,000 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 31.75% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Novo Nordisk's total carbon footprint was Scope 3 emissions, accounting for 89.29% of the company's total carbon footprint, followed by Scope 2 emissions at 7.19%. a

Want Full Access to Novo Nordisk's GHG Emissions Dataset?
Sign Up